Mizuho Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $18.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective decreased by Mizuho from $21.00 to $18.00 in a research note published on Thursday morning,Benzinga reports. Mizuho currently has a neutral rating on the medical instruments supplier’s stock.

A number of other research analysts have also recently weighed in on the stock. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Barrington Research dropped their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Morgan Stanley decreased their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Finally, Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Twelve equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Trading Down 2.2 %

Shares of XRAY opened at $15.00 on Thursday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a 50 day simple moving average of $18.35 and a 200-day simple moving average of $20.97. DENTSPLY SIRONA has a 1-year low of $14.77 and a 1-year high of $34.16. The stock has a market cap of $2.98 billion, a price-to-earnings ratio of -7.25, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.27%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link. 0.52% of the stock is owned by company insiders.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds have recently made changes to their positions in the stock. Colonial Trust Co SC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $26,000. Riverview Trust Co acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares in the last quarter. Finally, Van ECK Associates Corp acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $42,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.